光刻膠板塊走強 中科院將部署光刻機等“卡脖子”領域攻關
格隆匯9月17日丨光刻膠板塊拉昇走強,廣信材料大漲10%,奧普光電拉昇封板,揚帆新材、高盟新材、藍英裝備、容大感光等跟漲。昨日,中科院院長白春禮在中國科學院“率先行動”計劃第一階段實施進展發佈會上表示:面臨美國對中國高科技產業的打壓,我們希望在這方面能做一些工作。我們把美國“卡脖子”的清單變成我們科研任務清單進行佈局,比如航空輪胎、軸承鋼、光刻機,還有一些關鍵的核心技術、關鍵原材料等,我們爭取將來在第二期,聚焦在國家最關注的重大的領域,集中我們全院的力量來做。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.